Danaher Life Sciences News and Activities

Danaher Life Sciences is owned by Danaher.

Danaher is one of the...

• Forbes Global 2000 (#241);
• Fortune 500 (#153);
• Russell 3000;
• S&P 500;
• TOB Iconic 10,000.

Danaher is a company listed under the stock ticker DHR (US).

Danaher has a direct presence in 10 countries.

Danaher has 26 subsidiaries including AB Sciex, Aldevron and Apex Tool Group.

They are in:

• Medical Equipment44%
• Biotechnology26%
• Other30%

Acquisition, funding and merger involving Danaher.

• Danaher has announced the acquisition of Masimo  (posted on May 5 2026).
• Danaher has announced the acquisition of Masimo  (posted on February 24 2026).
• Danaher has announced the acquisition of Masimo  (posted on February 23 2026).
• Danaher has announced the acquisition of Masimo  (posted on February 18 2026).
• See more news about Danaher Hide news involving Danaher

View the org chart displaying its 5 main executives

Most searched biographies at Danaher Life Sciences

• Rainer Blair, Executive Vice President and President
• Daniel Nothelfer, Vice President, Instrumentation
• Naresh Narasimhan, Vice President, Executive Life Sciences Innovat...

Popular executive movements at Danaher Life Sciences

• Naresh Narasimhan, who was Vice President, Executive High Growth Markets & Pall, is promoted to Vice President, Executive Life Sciences Innovations Group & High Growth Markets  (posted on January 12 2026).

Popular executive movements at Danaher

• Angela Blake, who was Director of Talent Development, is promoted to Senior Director, Leadership Development Portfolio  (posted on January 12 2026).
• Martin Stumpe who was Chief Data & Artificial Intelligence Officer, becomes Chief Technology and Artificial Intelligence Officer  (posted on November 3 2025).

Create your alert
to follow the executive moves at Danaher Life Sciences.

Danaher has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Danaher Life Sciences

Social media about Danaher Life Sciences

• Danaher Life Sciences on Wikipedia, Google News & Yahoo Finance
• Danaher Life Sciences on LinkedIn, X (Twitter) & YouTube